Generic Declared Spectacular Results,Gets Buy Rating from Analyst

By | May 26, 2018

Generic Construction we have been covering this stock technically in past many post, Last Friday it did the target of 327 as per our last post.

Generic declared its results on 19 April, below are the highlights of the results.

Excellent news for all share-holders of Generic Engineering and Construction

• Results
-Revenue : 138.9cr in FY18 vs 38.56cr in FY17 ( 260% increase)
-Profit : 15.65cr in FY18 vs 2.24cr in FY17 ( 598% increase )

• Dividend
-Rs 0.10/equity share of Face Value 10

• Split
-Stock split from 1 share of Face Value 10 to 2 shares of Face Value 5

 

I will analyze Stock Technically and post my analysis at the right time.

Below are few links I cam across regarding Generic, Whole Purpose of sharing is to get to know about management better and to prove Price knows everything well in advance. Follow Price and News will follow.

Few Analyst even gave the Buy Target of Rs 400

Generic Engineering Construction and Projects Ltd.: Buy Generic Engineering Construction and Projects, target Rs 400: Rakesh Bansal – The Economic Times –

CFO Interview — https://www.indiainfoline.com/article/editorial-interviews-leader-speak/tarak-bipinchandra-gor-cfo-and-whole-time-director-gecpl-118052300013_1.html

Below the Interview they had on CNBC Awaz

 

 

The above Stocks is not investment pick as I am not expert in Fundamental analysis but a short term pick for gain of 10-20% purely based on Technical Analysis based on my Studies.Please also do your own study before trading this stock and trade in small quantity also be strict with Stoploss.Bramesh Bhandari and his family/associates/ analysts would have exposure in the securities mentioned in the above article.

2 thoughts on “Generic Declared Spectacular Results,Gets Buy Rating from Analyst

  1. Bramesh Post author

    Dear Sir,

    With all due respect to your analysis below are my 2 cents.

    At Rs 190 rs company raised 70-80 cr its debt free equity capital, 70-80 cr is not a small amount when market conditions are not good and many small caps getting beaten to pulp. Overall company remains a debt free.

    Marquee orders are continuing,reliance healthcare project complete as per disclosure on BSE site. Order books remains healthy.

    Regarding Promoter holding coming down before pref cap it was 60%+ after pre-cap done 46-47 lakh shares allocated out of which promoters have also subscribed to 21-22 lakh@190 and rest public has subscribed to which shows promoters have full faith in the company and their order execution capability.

    Difference of 25 lakh reduced to promoter reducing stake but it also increased the equity base of the company.They have not sold a “single physical share in open market.”

    Above information is all available on BSE Site.

    Links shared in above post Analyst gave target of Rs 400 and management seems very confident which was also reflected in results declared last week.

    I rest my case.

    Rgds,
    Bramesh

  2. Rajiv Jamwal

    pe 55,Macp/sales 4.50, book value just 32, promoters reducing the stake…Fundamentals dnt justify this price

Leave a Reply